Steven Compton, MD
Clinical Cardiac Electrophysiology · Anchorage, AKNPI 1548285901
Payments from drug & device makers
Across 242 payments — averaging $720.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$129K
- Abbott$15K
- Boehringer Ingelheim$14K
- Boston Scientific$13K
- Biosense Webster, Inc.$1K
- Atricure, Inc.$771
- plus $1K from 8 others
What the payments were for
- Consulting fees$25,90164%
- Speaking & faculty fees$5001%
- Travel & lodging$7,59019%
- Food & beverage$6,34016%
- Education$4201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 101 | $129,159 |
| Abbott | 50 | $15,471 |
| Boehringer Ingelheim | 2 | $13,680 |
| Boston Scientific | 46 | $12,931 |
| Biosense Webster, Inc. | 15 | $1,057 |
| Atricure, Inc. | 14 | $771 |
| Cardiva Medical, Inc. | 1 | $500 |
| Impulse Dynamics (USA) Inc. | 2 | $263 |
| Biotronik Inc. | 2 | $221 |
| E.r. Squibb & Sons, L.L.C. | 2 | $123 |
| Novartis | 4 | $96 |
| Cleerly, Inc. | 1 | $93 |
| Cook Medical LLC | 1 | $18 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$1,689
- AVEIR$1,426
- Carto 3$600
- OPTIMIZER$526
- Vascular Closure Device$500
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$410
- TENDRIL$271
- Assurity Pacemaker$149
- Azure$138
- Arctic Front$124
- GALLANT$122
- SYNERGY ABLATION SYSTEM$119
- CAMZYOS$109
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$101
How this compares
Too few clinical cardiac electrophysiology providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 309 | $404,105 |
| XareltoRivaroxaban | 85 | $127,508 |
| MultaqDronedarone Hcl | 40 | $66,128 |
| Propafenone Hcl ErPropafenone Hcl | 14 | $3,879 |
| Metoprolol Succinate | 78 | $1,658 |
| ClopidogrelClopidogrel Bisulfate | 29 | $761 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $600 |
| Amiodarone Hcl | 12 | $290 |
| Carvedilol | 13 | $247 |
| Atorvastatin Calcium | 15 | $206 |
| Warfarin Sodium | 14 | $196 |
| Metoprolol Tartrate | 14 | $90 |
| Losartan Potassium | 13 | $73 |
| Lisinopril | 19 | $53 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Anchorage
- Mark WillcoxAnchorage$79K
- Yiming WuAnchorage$5K
- Krzysztof BalabanAnchorage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.